These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
[ X ]
|
Annual Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
|
|
For the Fiscal Year Ended December 31, 2011
|
|
|
[ ]
|
Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
|
|
Nevada
|
87-0645394
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
| Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. | Yes [ ] No [ X ] |
| Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. |
Yes [ ] No [ X ]
|
| Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. |
Yes [ X ] No [ ]
|
| Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). | Yes [ ] No [ X ] |
| Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. |
[ ]
|
|
Large accelerated filer
|
[ ]
|
Accelerated filer
|
[ ]
|
|
Non-accelerated filer
|
[ ]
|
Smaller reporting company
|
[X]
|
|
(Do not check if a smaller reporting company)
|
|||
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
|
Yes [ ] No [ X ]
|
|
Page
|
||
|
PART I
|
||
|
Item 1.
|
Business
|
3
|
|
Item 1A.
|
Risk Factors
|
6
|
|
Item 1B.
|
Unresolved Staff Comments
|
9
|
|
Item 2.
|
Properties
|
9
|
|
Item 3.
|
Legal Proceedings
|
9
|
|
Item 4.
|
Removed and Reserved
|
9
|
|
PART II
|
||
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
9
|
|
Item 6.
|
Selected Financial Data
|
11
|
|
Item 7.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
11
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
15
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
15
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
15
|
|
Item 9A(T).
|
Controls and Procedures
|
15
|
|
Item 9B
|
Other Information
|
16
|
|
PART III
|
||
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
16
|
|
Item 11.
|
Executive Compensation
|
18
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
18
|
|
Item 13.
|
Certain Relationships and Related Transactions and Director Independence
|
18
|
|
Item 14.
|
Principal Accounting Fees and Services
|
18
|
|
PART IV
|
||
|
Item 15.
|
Exhibits, Financial Statement Schedules.
|
19
|
|
Signatures
|
30
|
|
|
●
|
the ability to secure adequate funding to increase marketing and fund future production of our product;
|
| ● | |
|
●
|
the size and timing of future customer orders, product delivery and customer acceptance, if required;
|
| ● | |
|
●
|
the costs of maintaining and expanding operations; and
|
| ● | |
|
●
|
the ability to attract and retain a qualified work force as business warrants.
|
|
●
|
make a special suitability determination for purchasers of the shares;
|
|
●
|
receive the purchaser's written consent to the transaction prior to the purchase; and
|
|
●
|
deliver to a prospective purchaser of our shares prior to the first transaction, a risk disclosure document relating to the penny stock market.
|
| Item 1B. | Unresolved Staff Comments |
| Item 2 | Properties |
| Item 3. | Legal Proceedings |
| Item 4. | Removed and Reserved |
| Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |
|
●
|
the average weekly trading volume in the common stock, as reported through the automated quotation system of a registered securities association, during the four calendar weeks preceding such sale, or
|
|
●
|
1% of the shares then outstanding.
|
|
Item 6.
|
Selected Financial Data
|
|
Item 7.
|
Management's Discussion and Analysis of Financial Condition and Results of Operation
|
|
●
|
the ability to maintain current business and, if feasible, expand the marketing of products;
|
|
●
|
the ability to attract and retain new individual and retail customers;
|
|
●
|
the sufficiency of existing capital resources and the ability to raise additional capital to fund cash requirements for future operations;
|
|
●
|
uncertainties involved in the rate of growth of business and acceptance of our product and;
|
|
|
|
|
●
|
anticipated size or trends of the market segments in which we compete and the anticipated competition in those markets;
|
|
●
|
future capital requirements and our ability to satisfy these needs;
|
|
●
|
general economic conditions.
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures Bout Market Risk
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
|
Item 9A.
|
Controls and Procedures
|
|
●
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and disposition of our assets;
|
|
●
|
provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and that receipts and expenditures are being made only with proper authorizations of management and directors; and
|
|
●
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of company assets that could have a material effect on the financial statements.
|
|
Item 9B.
|
Other Information
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
|
Name
|
Age
|
Position
|
|
George I. Norman III
|
58
|
President, Chief Executive Officer and Director
|
|
Laurie J. Norman
|
49
|
Secretary / Treasurer and Director
|
|
Jessie Scott Bean
|
57
|
Director
|
|
Item 11.
|
Executive Compensation
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
| Name and Address of Beneficial Owner |
Amount and Nature of Beneficial Ownership
|
Percent of Class
(
1)
|
||
|
Alewine Limited Liability Company
(2)
|
1,863,475
|
71%
|
||
|
1390 South 1100 East Ste. 204
|
||||
|
Salt Lake City, UT 84105
|
||||
|
Jessie Scott Bean
|
20,000
|
1%
|
||
|
8313 Aspenbrook
|
||||
|
Las Vegas, NV 89145
|
||||
|
All directors and officers as
|
1,883,475
|
72%
|
||
|
a group (3 persons)
|
|
|
Note:
|
Unless otherwise indicated, we have been advised that each person above has sole voting power over the shares indicated above.
|
|
(2)
|
Alewine Limited Liability Company is a Nevada limited liability company managed by Mr. Norman, our President, through which he manages his personal investments and conducts his self-employment consulting business in the area of real estate management and corporate finance. Alewine Limited Liability Company is owned by George Norman and Laurie Norman, our Secretary. By resolution of its members, Mr. Norman has voting and investment control over Alewine.
|
|
Item 13.
|
Certain Relationships and Related Transactions and Director Independence
|
|
Item 14.
|
Principal Accountant Fees and Services
|
|
Item 15.
|
Exhibits, Financial Statement Schedules
|
|
(a)
Exhibits
|
||
|
Exhibit No.
|
Exhibit Name
|
|
|
3.1*
|
Articles of Incorporation (Nevada)
|
|
|
3.2*
|
By-Laws of Registrant
|
|
|
4.1*
|
Instrument defining rights of holders (See Exhibit No. 3.1, Articles of Incorporation)
|
|
|
10.1**
|
Promissory Note
|
|
|
21.1*
|
Subsidiaries
|
|
|
31.1
|
Certification of C.E.O Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification of Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
Certification of C.E.O. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
Certification of Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101
ins
|
XBRL Instance
|
|
|
101.xsd
|
XBRL Schema
|
|
|
101.cal
|
XBRL Calculation
|
|
|
101.def
|
XBRL Definition
|
|
|
101.lab
|
XBRL Label
|
|
|
101.pre
|
XBRL Presentation
|
|
|
December 31,
|
December 31,
|
|||||||||
|
2011
|
2010
|
|||||||||
|
Assests
|
||||||||||
|
Current Assests
|
||||||||||
|
Cash
|
$ | - | $ | - | ||||||
|
Deposits
|
- | 2,990 | ||||||||
|
Inventory
|
2,454 | - | ||||||||
|
|
Total Current Assets
|
$ | 2,454 | $ | 2,990 | |||||
|
Equipment-Production Mold, Net
|
$ | 1,360 | $ | 1,700 | ||||||
|
Total Assets
|
$ | 3,814 | $ | 4,690 | ||||||
|
Liabilities & Stockholders' Deficiency
|
||||||||||
|
Current Liabilities
|
||||||||||
|
Accounts Payable
|
$ | 20,874 | $ | 31,304 | ||||||
|
Notes Payable- Related Party
|
46 , 153 | 24,774 | ||||||||
|
Total Current Liabilities
|
$ | 67,027 | $ | 56,078 | ||||||
|
Stockholders' Deficiency
|
||||||||||
|
Common Stock
|
||||||||||
|
25,000,000 shares authorized at $0.001 par value; 2,633,750 shares issued and outstanding
|
$ | 2,634 | $ | 2,634 | ||||||
|
Capital in excess of par value
|
147,561 | 147,561 | ||||||||
|
Accumulated deficit during development stage
|
(213,408 | ) | (201,583 | ) | ||||||
|
Total Stockholders' Deficiency
|
$ | (63,213 | ) | $ | (51,388 | ) | ||||
|
Total Liabilities and Stockholders' Deficiency
|
$ | 3,814 | $ | 4,690 | ||||||
|
December 31,
|
December 31,
|
April 22, 1997
|
|||||||||||
|
2011
|
2010
|
to December 31, 2011
|
|||||||||||
|
Sales
|
$ | 19,747 | $ | 6,861 | $ | 49,591 | |||||||
|
Cost of Goods Sold
|
$ | (2,526 | ) | - | $ | (2,526 | ) | ||||||
|
Gross Profit
|
$ | 17,221 | $ | 6,861 | $ | 47,065 | |||||||
|
Expenses
|
|||||||||||||
|
General and administrative
|
$ | 28,453 | $ | 20,279 | $ | 230,995 | |||||||
|
Royalties
|
253 | 75 | 488 | ||||||||||
|
Depreciation and amortization
|
340 | - | 28,990 | ||||||||||
| $ | 29,046 | $ | 20,354 | $ | 260,473 | ||||||||
|
Net Loss
|
$ | (11,825 | ) | $ | (13,493 | ) | $ | (213,408 | ) | ||||
|
Net Loss Per Common Share
|
|||||||||||||
|
Basic and dilluted
|
$ | (0.00 | ) | $ | (0.01 | ) | |||||||
|
Weighted Average Outstanding Shares
|
|||||||||||||
|
Basic and diluted (stated in 1000's)
|
2,634 | 2,624 | |||||||||||
|
Accumulated
|
||||||||||||||||||||
|
Capital in
|
Deficit
|
|||||||||||||||||||
| Common Stock |
Excess of
|
during
|
||||||||||||||||||
|
Shares
|
Amount
|
Par Value
|
Development Stage
|
Total
|
||||||||||||||||
|
Balance December 30, 1999 (predecessor)
|
$ | $ | 51,977 | $ | (51,977 | ) | $ | - | ||||||||||||
|
Issuance of common shares for cash and
a patent at .0129-December 30, 1999
|
1,000,000 | 1,000 | 11,963 | 12,963 | ||||||||||||||||
|
Net operating loss for the year ended
31-Dec-00
|
(8,867 | ) | (8,867 | ) | ||||||||||||||||
|
Inssuance of common shares for cash
at .025-June 27, 2001
|
800,000 | 800 | 19,200 | 20,000 | ||||||||||||||||
|
Issuance of common shares for cash
at .025-August 31, 2001
|
20,000 | 20 | 480 | 500 | ||||||||||||||||
|
Stock offering costs
|
(375 | ) | (375 | ) | ||||||||||||||||
|
Capital contribution- related party
|
100 | 100 | ||||||||||||||||||
|
Net operating loss for the year ended
31-Dec-01
|
(13,537 | ) | (13,537 | ) | ||||||||||||||||
|
Stock offering costs
|
(2,500 | ) | (2,500 | ) | ||||||||||||||||
|
Net operating loss for the year ended
31-Dec-02
|
(13,858 | ) | (13,858 | ) | ||||||||||||||||
|
Issuance of common shares for cash
at .08 Feb 20 2003
|
763,750 | 764 | 60,336 | 61,100 | ||||||||||||||||
|
Stock offering costs
|
(6,070 | ) | (6,070 | ) | ||||||||||||||||
| - | ||||||||||||||||||||
|
Net operating loss for the year ended
31-Dec-03
|
(18,081 | ) | (18,081 | ) | ||||||||||||||||
|
Net operating loss for the year ended
31-Dec-04
|
(1,731 | ) | (1,731 | ) | ||||||||||||||||
|
Net operating loss for the year ended
31-Dec-05
|
(12,692 | ) | (12,692 | ) | ||||||||||||||||
|
Net operating loss for the year ended
31-Dec-06
|
(15,821 | ) | (15,821 | ) | ||||||||||||||||
|
Net operating loss for the year ended
31-Dec-07
|
(19,881 | ) | (19,881 | ) | ||||||||||||||||
|
Net operating loss for the year ended
31-Dec-08
|
(14,674 | ) | (14,674 | ) | ||||||||||||||||
|
Issuance of common shares for cash
at .25 Nov 03 2009
|
20,000 | 20 | 4,980 | 5,000 | ||||||||||||||||
|
Net operating loss for the year ended
31-Dec-09
|
(16,971 | ) | (16,971 | ) | ||||||||||||||||
|
Issuance of common shares for cash
at .25 Apr 06 10
|
20,000 | 20 | 4,980 | 5,000 | ||||||||||||||||
|
Issuance of common shares for cash
at .25 Jun 29 10
|
10,000 | 10 | 2,490 | 2,500 | ||||||||||||||||
|
Net operating loss for the year
ended December 31,2010
|
(13,493 | ) | (13,493 | ) | ||||||||||||||||
|
Balance December 31, 2010
|
2,633,750 | $ | 2,634 | $ | 147,561 | $ | (201,583 | ) | $ | (51,388 | ) | |||||||||
|
Net operating loss for the year
ended December 31, 2011
|
(11,825 | ) | (11,825 | ) | ||||||||||||||||
|
Balance December 31, 2011
|
2,633,750 | $ | 2,634 | $ | 147,561 | $ | (213,408 | ) | $ | (63,213 | ) | |||||||||
|
December 31,
|
December 31,
|
April. 22, 1997 to
|
||||||||
|
2011
|
2010
|
December 31, 2011
|
||||||||
|
Cash Flows From
Operating Activities
|
||||||||||
|
Net Loss
|
$ | (11,825 | ) | $ | (13,493 | ) | $ | (213,408 | ) | |
|
Adjustments to reconcile net loss to
net cash provided by operating activities
|
||||||||||
|
Contributions to capital- expenses
|
100 | |||||||||
|
Issuance of common stock for expenses
|
- | - | 8,700 | |||||||
|
Depreciation and amortization
|
340 | - | 28,990 | |||||||
|
Changes in operating assets and liabilities:
|
||||||||||
|
Inventory
|
536 | (2,990 | ) | (2,454 | ) | |||||
|
Accounts payable
|
(10,430 | ) | 11,249 | 17,653 | ||||||
|
Net Cash Flows (Used in) Operations
|
$ | (21,379 | ) | $ | (5 ,234 | ) | $ | (160,419 | ) | |
|
Cash Flows From Investing Activities
|
||||||||||
|
Purchase of patent
|
$ | - | $ | - | $ | (28,650 | ) | |||
|
Purchase of Equipment
|
- | (1,700 | ) | (1,700 | ) | |||||
|
Purchase office equipment
|
- | - | (2,096 | ) | ||||||
|
Net Cash Flows (Used in) Investing Activities
|
$ | - | $ | (1,700 | ) | $ | (32,446 | ) | ||
|
Cash Flows From Financing Activities
|
||||||||||
|
Notes Payable from related party
|
$ | 27,025 | $ | 8,866 | $ | 61,488 | ||||
|
Payments to related party
|
(5,646 | ) | (9,689 | ) | (15,335 | ) | ||||
|
Proceeds from issuance of common stock
|
- | 7,500 | 146,712 | |||||||
|
Net Cash Flows provided by Financing Activities
|
$ | 21,379 | $ | 6,677 | $ | 192,865 | ||||
|
Net Change in Cash
|
$ | - | $ | (257 | ) | $ | - | |||
|
Cash at Beginning of Period
|
- | 257 | - | |||||||
|
Cash at End of Period
|
$ | - | $ | - | $ | - | ||||
|
SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING ACTIVITIES
|
||||||||||
|
Issuance of 922,900 common shares for a patent- 2000
|
$ |
11,963
|
||||||||
|
Contributions to capital- expenses- 2001
|
$ | 100 | ||||||||
| LILM, Inc. |
| By: /S/ George I. Norman, III |
| George I. Norman, III |
| President and C.E.O. |
|
Signature
|
Title
|
Date
|
|
|
||
|
|
||
|
/S/
George I. Norman, III
|
President, C.E.O. and director
|
March 30, 2012
|
|
George I. Norman, III
|
(Principal Accounting Officer)
|
|
|
/S/
Laurie J. Norman
|
Secretary / Treasurer and Director
|
March 30, 2012
|
|
Laurie J. Norman
|
||
|
/S/
Jessie Scott Bean
|
Director
|
March 30, 2012
|
|
Jessie Scott Bean
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|